As a Free StocksGuide user, you can view scores for all 7,009 stocks worldwide.
10 Analysts have issued a Heron Therapeutics Inc forecast:
10 Analysts have issued a Heron Therapeutics Inc forecast:
Mar '25 |
+/-
%
|
||
Revenue | 149 149 |
12%
12%
|
|
Gross Profit | 110 110 |
46%
46%
|
|
EBITDA | -0.52 -0.52 |
99%
99%
|
EBIT (Operating Income) EBIT | -2.88 -2.88 |
97%
97%
|
Net Profit | -7.79 -7.79 |
90%
90%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Heron Therapeutics, Inc. is a biotechnology company, which engages in the development of pharmaceutical products for patients suffering from cancer. Its products portfolio include SUSTOL, Cinvanti, HTX-011, and HTX-034. The company was founded in February 1983 and is headquartered in Redwood City, CA.
Head office | United States |
CEO | Craig Collard |
Employees | 122 |
Founded | 1983 |
Website | www.herontx.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.